STRS Ohio’s Co-Diagnostics CODX Stock Holding History

STRS Ohio’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-223	Closed	-$129K	–	2210
2020 Q2	$129K	Buy	+223	New	+$102K	﹤0.01%	1734

Other funds holding CODX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

IFG Advisory Atlanta, Georgia $34.9M AUM 20.48% 1-Year Est. Return

STRS Ohio's CODX Position: Q3 2020 in Review

STRS Ohio sold out of Co-Diagnostics (CODX) in Q3 2020, closing a stake of 223 shares — an estimated $129K sold.

STRS Ohio first reported a position in CODX in Q2 2020 and held it in 1 quarter. The position peaked at $129K in Q2 2020. 81 funds tracked by Wall St. Rank hold CODX as of Q3 2020.

STRS Ohio reported no remaining Co-Diagnostics position as of Q3 2020 after selling out during the quarter.
STRS Ohio sold 223 Co-Diagnostics shares in Q3 2020, an estimated $129K.
STRS Ohio first reported a position in Co-Diagnostics in Q2 2020 and held it in 1 quarter.
STRS Ohio's Co-Diagnostics position peaked at $129K in Q2 2020.
81 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2020.

Based on STRS Ohio's 13F filing for Q3 2020, filed 14 Dec 2020.